Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a yearlong campaign to ...
People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.
The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat diabetes, these drugs are now widely used for weight loss and have become ...
This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.
Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and ...
You’ve heard of the rise of “Ozempic babies” — where women who’ve previously struggled with infertility get knocked up on GLP-1s — but new research shows that going off those drugs may have a negative ...
GLP-1 receptor agonists like semaglutide are being used off-label by healthy people hoping to slow ageing, despite limited evidence and unknown long-term risks.
Add Yahoo as a preferred source to see more of our stories on Google. Empower Pharmacy CEO Shaun Noorian is reflected in the pharmacy doors at a 2016 celebration of the reinvention and expansion of ...
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. With cold and flu season in full swing, you might be ...